ArticleCrohn's & colitis 3602026

Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk.

Paraj Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.